SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-005865
Filing Date
2017-05-25
Accepted
2017-05-25 06:10:11
Documents
10
Period of Report
2017-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 31712
2 ex10-1.htm EX-10.1 223963
3 ex10-2.htm EX-10.2 165453
4 ex10-3.htm EX-10.3 44318
5 ex99-1.htm EX-99.1 13542
6 ex99-2.htm EX-99.2 9507
7 ex10-1_001.jpg GRAPHIC 34908
8 ex99-1_001.jpg GRAPHIC 4520
9 ex99-1_002.jpg GRAPHIC 4753
10 image_001.jpg GRAPHIC 16080
  Complete submission text file 0001493152-17-005865.txt   573601
Mailing Address 38 WEST MAIN STREET HANCOCK MD 21750
Business Address 38 WEST MAIN STREET HANCOCK MD 21750 844-473-8543
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52445 | Film No.: 17868227
SIC: 2860 Industrial Organic Chemicals